- Pathological tau alters head direction signaling and induces spatial disorientation
- Mental Tasks Induce Common Modulations of Oscillations in Cortex and Spinal Cord
- Correction of RBFOX1 deficit rescues Huntington's disease mis-splicing and pathology
- Accelerated Simulations Reveal Physicochemical Factors Governing Stability and Composition of RNA Clusters
- Restoring Compromised Cl<sup>-</sup> in D2 Neurons of a HD Mouse Model Rescues Motor Disability
- UBE3A: Bridging the gap between neurodevelopment, neural function, and neurodegenerative woes
- Direct observation of secondary nucleation in huntingtin amyloid formation by High-Speed Atomic Force Microscopy
- Mitochondrial dysfunction and inflammasome activation in neurodegenerative diseases: Mechanisms and therapeutic implications
- Therapeutic potentials of cannabidiol: Focus on the Nrf2 signaling pathway
- Suppression of Huntington's Disease Somatic Instability by Transcriptional Repression and Direct CAG Repeat Binding
- F2,6BP restores mitochondrial genome integrity in Huntingtons Disease
- Recent pharmacological insights on abating toxic protein species burden in neurological disorders: Emphasis on 26S proteasome activation
- The cGAS-STING pathway drives neuroinflammation and neurodegeneration via cellular and molecular mechanisms in neurodegenerative diseases
- On the neural substrates of mind wandering and dynamic thought: A drug and brain stimulation study
- Response to Letter to the Editor: Causal associations of physical activity and leisure sedentary behaviors with age at onset of Huntington's disease: A Mendelian randomization study
- Interplay between Sex and Disease Burden in Huntington's Disease: Clinical and Neuroimaging Perspectives
- Proteomimetic polymer blocks mitochondrial damage, rescues Huntington's neurons, and slows onset of neuropathology in vivo
- Transposable element small and long RNAs in aging brains and implications in Huntington's and Parkinson's disease
- "I Wouldn't Even Know What to Ask for": Patients' and Caregivers' Experiences of Psychological Support for Huntington's Disease in Italy
- Dendritome Mapping Unveils Spatial Organization of Striatal D1/D2-Neuron Morphology
- Role of Thrombosis in Neurodegenerative Diseases: An Intricate Mechanism of Neurovascular Complications
- From the fly connectome to exact ring attractor dynamics
- Neurexin1 level in Huntington's Disease and decreased Neurexin1 in disease progression
- Randomized Trial of Telegenetic Counseling for Gene Testing in Huntington Disease
- Machine learning-based radiomics in neurodegenerative and cerebrovascular disease
- The role of ferroptosis in neurodegenerative diseases
- Dynamic entrainment: A deep learning and data-driven process approach for synchronization in the Hodgkin-Huxley model
- Impaired striatal glutathione-ascorbate metabolism induces transient dopamine increase and motor dysfunction
- Quinic acid protects against the development of Huntington's disease in Caenorhabditis elegans model
- Preferences for genetic interventions for SCA and Huntington's disease: results of a discrete choice experiment among patients
- CNN-Based Neurodegenerative Disease Classification Using QR-Represented Gait Data
- Enhanced Hippocampal Spare Capacity in Q175DN Mice Despite Elevated mHTT Aggregation
- Corticostriatal Maldevelopment in the R6/2 Mouse Model of Juvenile Huntington's Disease
- Post-translational modifications orchestrate the intrinsic signaling bias of orphan receptor GPR52
- Diagnostic and mechanistic roles of MicroRNAs in neurodevelopmental & neurodegenerative disorders
- Brain Volumetric Analysis Using Artificial Intelligence Software in Premanifest Huntington's Disease Individuals from a Colombian Caribbean Population
- The Microbiota-Gut-Brain Axis and Neurological Disorders: A Comprehensive Review
- Unveiling the Potential of Phytocannabinoids: Exploring Marijuana's Lesser-Known Constituents for Neurological Disorders
- Dual Role of Anionic Lipids in Amyloid Aggregation
- Overcoming Graft Rejection in Induced Pluripotent Stem Cell-Derived Inhibitory Interneurons for Drug-Resistant Epilepsy
- Investigating the Interplay between Cardiovascular and Neurodegenerative Disease
- The Emerging Role of Phosphodiesterase 5 Inhibition in Neurological Disorders: The State of the Art
- UBL3 Interacts with PolyQ-Expanded Huntingtin Fragments and Modifies Their Intracellular Sorting
- Transposable element small and long RNAs in aging brains and implications in Huntington's and Parkinson's disease
- Interactions of Li<sup>+</sup> ions with NCS1: A potential mechanism of Li<sup>+</sup> neuroprotective action against psychotic disorders
- Neuroleptic malignant syndrome in Huntington disease
- Nanotechnology and CRISPR/Cas-Mediated Gene Therapy Strategies: Potential Role for Treating Genetic Disorders
- Huntington's disease phenocopy syndromes revisited: a clinical comparison and next-generation sequencing exploration
- Expanding the Phenotype of Extremely Early Onset Juvenile Huntington's Disease: A Case Report and Review of Previously Published Cases
- Dendritome Mapping Unveils Spatial Organization of Striatal D1/D2-Neuron Morphology
- SC10X/U: A High-density Electrode System for Non-Invasive Recording of Neural Activity of the Cervical Spinal Cord
- Mortality Risk Factors in Appalachian Burn Patients: A 13-Year Retrospective Study
- Visual objects refine head direction coding
- 5-HT2C receptors in the nucleus accumbens constrain the rewarding effects of MDMA
- Structural compromise in spiking cortex and connected networks
- Small organism models for mode of action research on anti-ageing and nootropic herbs, foods, and formulations
- Therapeutic approaches targeting aging and cellular senescence in Huntington's disease
- Caffeine Use in Huntington's Disease: A Single Center Survey
- Medication Use and Treatment Indications in Huntington's Disease; Analyses from a Large Cohort
- Epigenetic events influencing the biological clock: Panacea for neurodegeneration
- Mapping the glial transcriptome in Huntington's disease using snRNAseq: selective disruption of glial signatures across brain regions
- Nuclear proteasomes as a backup for autophagy: interconnected proteostasis pathways
- ENACT: End-to-End Analysis of Visium High Definition (HD) Data
- Novel Prospects in Targeting Neurodegenerative Disorders via Autophagy
- Multimodal action of phosphodiesterase 5 inhibitors against neurodegenerative disorders: An update review
- The Role of Sirtuin 1 in Ageing and Neurodegenerative Disease: A Molecular Perspective
- Combinations of physical and cognitive training for subcortical neurodegenerative diseases with physical, cognitive and behavioral symptoms: a systematic review
- Evolution of aberrant brain-wide spatiotemporal dynamics of resting-state networks in a Huntington's disease mouse model
- Imaging Glucose Metabolism and Dopaminergic Dysfunction in Sheep (Ovis aries) Brain Using Positron Emission Tomography Imaging Reveals Abnormalities in OVT73 Huntington's Disease Sheep
- Corticostriatal Maldevelopment in the R6/2 Mouse Model of Juvenile Huntington Disease
- Delineating the neural substrates of autobiographical memory impairment in Huntington's disease
- Cannabinoids shift the basal ganglia miRNA m6A methylation profile towards an anti-inflammatory phenotype in SIV-infected Rhesus macaques
- Structural and molecular basis of FAN1 defects in promoting Huntington's disease
- Exploring the Role of Deutetrabenazine in the Treatment of Chorea Linked with Huntington's Disease
- Designed Nanodrugs for Ultrasonic Removal of Toxic Polyglutamine Aggregates from Neuron Cells
- Glycosylation of chrysin with β-d-glucose tetraacetate (LQFM280) enhances its in vitro and in vivo neuroprotective effects against the toxicity induced by 3-nitropropionic acid
- Risk of Colorectal Cancer among Patients with One or Multiple Metabolic Syndrome Components
- Neuroprotective Potential of Eugenol in Polyglutamine-Mediated Neurodegenerative Disease Using Transgenic Drosophila Model
- Enhanced Hippocampal Spare Capacity in Q175DN Mice Despite Elevated mHTT Aggregation
- Autophagy, aging, and age-related neurodegeneration
- The pivotal role of histidine 976 in human histone deacetylase 4 for enzyme function and ligand recognition
- An insight into allele-selective approaches to lowering mutant huntingtin protein for Huntington's disease treatment
- Costs of Illness for Huntington's Disease: A Systematic Review
- Dissemination of VMAT-2 Inhibitors: A New Class Drug for Tardive Dyskinesia and Huntington Disease
- Exploring Place of Death Among Individuals With Huntington's Disease in the United States
- Immune signature of gene expression pattern shared by autism spectrum disorder and Huntington's disease
- Distortion errors characterise visuo-constructive performance in Huntington's disease
- Dysregulation of protein SUMOylation networks in Huntington's disease R6/2 mouse striatum
- Mechanistic insights on the role of Nrf-2 signalling in Huntington's disease
- m<sup>6</sup>A modification of mutant huntingtin RNA promotes the biogenesis of pathogenic huntingtin transcripts
- Reprogrammed Human Lateral Ganglionic Eminence Precursors Generate Striatal Neurons and Restore Motor Function in a Rat Model of Huntington's Disease.
- Differential impact of optogenetic stimulation of direct and indirect pathways from dorsolateral and dorsomedial striatum on motor symptoms in Huntington's disease mice
- Challenges and advances for huntingtin detection in cerebrospinal fluid: in support of relative quantification
- Treatment with Tau fibrils impact Huntington's disease-related phenotypes in cell and mouse models
- Stick-slip unfolding favors self-association of expanded HTT mRNA
- Elevated plasma and CSF neurofilament light chain concentrations are stabilized in response to mutant huntingtin lowering in the brains of Huntington's disease mice
- Small RNAs in plasma extracellular vesicles define biomarkers of premanifest changes in Huntington's disease
- Automatic selection model to identify neurodegenerative diseases
- Unraveling the Molecular Jam: How Crowding Shapes Protein Aggregation in Neurodegenerative Disorders
- The impact of diagnosing provider type on longitudinal care for patients with newly diagnosed Huntington's Disease
